Sex differences in cytokine responses to myelin peptides in multiple sclerosis

被引:64
作者
Pelfrey, CM
Cotleur, AC
Lee, JC
Rudick, RA
机构
[1] Cleveland Clin Fdn, Dept Neurosci, Cleveland, OH 44195 USA
[2] Case Western Reserve Univ, Inst Pathol, Cleveland, OH 44106 USA
[3] Cleveland Clin Fdn, Dept Biostat, Cleveland, OH 44195 USA
[4] Cleveland Clin Fdn, Dept Neurol, Cleveland, OH 44195 USA
关键词
multiple sclerosis; Th1/Th2; cytokines; gender differences; autoimmunity;
D O I
10.1016/S0165-5728(02)00224-2
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Many autoimmune diseases preferentially affect women; however, the underlying mechanisms for the sex differences are poorly understood. We examined sex-dependent differences in the immunologic response to myelin proteins in 22 multiple sclerosis (MS) patients and 22 healthy controls. Using ELISA spot assay (ELISPOT) methodology, interferon (IFN) gamma and IL-5 secretions were examined at the single cell level in response to overlapping proteolipid protein (PLP) peptides. As previously reported, we observed an overall disease effect in the IFNgamma response, such that MS patients were significantly higher than controls. With respect to PLP-induced IFNgamma secretion, both MS and control females responded higher than their corresponding males. Female MS patients demonstrated the highest responses compared to MS males or healthy controls of either sex. Although MS females had high IFNgamma responses to PLP, they had no IL-5 responses at all, suggesting strong Th1 skewing. In contrast, MS males had more IL-5 than control males, who lacked IL-5 responses. These IL-5 responses suggested that disease and gender are not independent, but rather interact to influence the cytokine response to myelin. The data suggest a gender bias towards Th1 responses in MS, which may contribute to the female predominance in this disease. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:211 / 223
页数:13
相关论文
共 52 条
[1]   INVIVO COMPETITION BETWEEN SELF PEPTIDES AND FOREIGN ANTIGENS IN T-CELL ACTIVATION [J].
ADORINI, L ;
MULLER, S ;
CARDINAUX, F ;
LEHMANN, PV ;
FALCIONI, F ;
NAGY, ZA .
NATURE, 1988, 334 (6183) :623-625
[2]   GENETIC-CONTROL OF THE CD4/CD8 T-CELL RATIO IN HUMANS [J].
AMADORI, A ;
ZAMARCHI, R ;
DESILVESTRO, G ;
FORZA, G ;
CAVATTON, G ;
DANIELI, GA ;
CLEMENTI, M ;
CHIECOBIANCHI, L .
NATURE MEDICINE, 1995, 1 (12) :1279-1283
[3]   Increased interleukin 12 production in progressive multiple sclerosis: Induction by activated CD4(+) T cells via CD40 ligand [J].
Balashov, KE ;
Smith, DR ;
Khoury, SJ ;
Hafler, DA ;
Weiner, HL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (02) :599-603
[4]   Low-dose estrogen therapy ameliorates experimental autoimmune encephalomyelitis in two different inbred mouse strains [J].
Bebo, BF ;
Fyfe-Johnson, A ;
Adlard, K ;
Beam, AG ;
Vandenbark, AA ;
Offner, H .
JOURNAL OF IMMUNOLOGY, 2001, 166 (03) :2080-2089
[5]   INCREASED PRODUCTION OF INTERFERON GAMMA AND TUMOR NECROSIS FACTOR PRECEDES CLINICAL MANIFESTATION IN MULTIPLE-SCLEROSIS - DO CYTOKINES TRIGGER OFF EXACERBATIONS [J].
BECK, J ;
RONDOT, P ;
CATINOT, L ;
FALCOFF, E ;
KIRCHNER, H ;
WIETZERBIN, J .
ACTA NEUROLOGICA SCANDINAVICA, 1988, 78 (04) :318-323
[6]  
Bettelli E, 1998, J IMMUNOL, V161, P3299
[7]   STRUCTURE OF THE HUMAN CLASS-I HISTOCOMPATIBILITY ANTIGEN, HLA-A2 [J].
BJORKMAN, PJ ;
SAPER, MA ;
SAMRAOUI, B ;
BENNETT, WS ;
STROMINGER, JL ;
WILEY, DC .
NATURE, 1987, 329 (6139) :506-512
[8]  
BUDD RC, 1987, J IMMUNOL, V138, P3583
[9]  
Correale J, 1998, J IMMUNOL, V161, P3365
[10]   Transgenic interleukin 10 prevents induction of experimental autoimmune encephalomyelitis [J].
Cua, DJ ;
Groux, H ;
Hinton, DR ;
Stohlman, SA ;
Coffman, RL .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (06) :1005-1010